HPV-test, Cervical Cancer and Follow-up

NCT02096016UNKNOWNOBSERVATIONAL

Summary

The investigators have planned this project to evaluate the follow-up program after surgery due to cervical cancer and to explore the possibilities for different tests of Human Papilloma Virus (HPV) in contributing to the customization of the follow-up program. Purpose: The investigators effort is to provide the background for an evidence-based update of the follow-up program after surgery due to cervical cancer with the purpose of early diagnosis of recurrence affecting quality of life for as few women as possible.

Key Facts

Lead Sponsor

University of Aarhus

Enrollment

50

Start Date

2014-01-01

Completion Date

2019-10-01

Study Type

OBSERVATIONAL

Official Title

Recurrence After Surgery for Cervical Cancer - an Evaluation of the Follow-up Program.

Interventions

Human Papilloma Virus test from the vaginal vault

Conditions

Human Papilloma VirusUterine Cervical NeoplasmsRecurrence

Eligibility

Age Range

18 Years+

Sex

FEMALE

Inclusion Criteria:

* Surgery. FIGO stage IA-IB. \> 18 years

Exclusion Criteria:

* Ajuvant oncologic treatment

Outcome Measures

Primary Outcomes

Prevalence of HPV Genotypes in Vagina (Type 16, 18 and Other)

Time frame: 2 years

Secondary Outcomes

HPV Clearance From Vagina in Between the Two Planned Follow-up Visits.

Time frame: 2 years

Locations

Aarhus University Hospital, Aarhus, Denmark

Linked Diseases

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms — a type of gynecological cancer.